These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35536077)

  • 1. The Importance of D-Dimer, Ferritin, CRP and Lymphocyte Values in Determining Mortality in COVID-19 Disease in Turkey.
    Topcu H; Arik YE
    Clin Lab; 2022 May; 68(5):. PubMed ID: 35536077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome.
    Yousaf MN; Sarwar S; Tarique S; Ahmed M; Tahir H
    J Coll Physicians Surg Pak; 2022 Jan; 32(1):37-41. PubMed ID: 34983145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The study of serum hsCRP, ferritin, IL-6 and plasma D-dimer in COVID-19: a retrospective study.
    Ahirwar AK; Takhelmayum R; Sakarde A; Rathod BD; Jha PK; Kumawat R; Gopal N
    Horm Mol Biol Clin Investig; 2022 Sep; 43(3):337-344. PubMed ID: 35357792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
    Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
    Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience.
    Ayhan M; Odabas H; Turan N; Ozyukseler DT; Kostek O; Alkan G; Abamor E; Yildirim ME
    J Chemother; 2021 Nov; 33(7):499-508. PubMed ID: 34032198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19.
    Huyut MT; Huyut Z
    Int Immunopharmacol; 2021 Nov; 100():108127. PubMed ID: 34536746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Values of Serum Ferritin and D-Dimer Trajectory in Patients with COVID-19.
    Qeadan F; Tingey B; Gu LY; Packard AH; Erdei E; Saeed AI
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33807920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.
    Abdelhady SA; Rageh F; Ahmed SS; Al-Touny SA; Riad E; Elhoseeny MM; Khalifa AA; Salim A; Farghly MI; Elgamal R
    Egypt J Immunol; 2022 Apr; 29(2):57-67. PubMed ID: 35436055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Analytical Values D-Dimer, Glucose, Ferritin and C-Reactive Protein of Symptomatic and Asymptomatic COVID-19 Patients.
    Pérez-García N; García-González J; Requena-Mullor M; Rodríguez-Maresca MÁ; Alarcón-Rodríguez R
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.
    Huang CY; Tsai HW; Liu CY; Liu TH; Huang HL; Chang CC; Chen WC; Sun JT
    Chin J Physiol; 2021; 64(6):306-311. PubMed ID: 34975124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.
    Zhao Y; Yin L; Patel J; Tang L; Huang Y
    J Med Virol; 2021 Jul; 93(7):4358-4369. PubMed ID: 33739452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying the Probable Etiology of Acute Undifferentiated Fever through Inflammatory Markers.
    Govindaraj V; Poonia D; Bhardwaj G; Balasubramani S; Michael B
    J Assoc Physicians India; 2024 May; 72(5):13-16. PubMed ID: 38881103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers and short-term prognosis in COVID-19.
    Peiró ÓM; Carrasquer A; Sánchez-Gimenez R; Lal-Trehan N; Del-Moral-Ronda V; Bonet G; Fort-Gallifa I; Picó-Plana E; Bastón-Paz N; Gutiérrez C; Bardaji A
    Biomarkers; 2021 Mar; 26(2):119-126. PubMed ID: 33426934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of clinically relevant serum proteins as biomarkers for monitoring COVID-19 severity, and end-organ damage among hospitalized unvaccinated patients.
    Elhommosani MR; Sakr MM; Abbas RM; Aboshanab KM
    BMC Infect Dis; 2024 Feb; 24(1):231. PubMed ID: 38378528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
    Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
    Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
    Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic yield of bacteriological tests and predictors of severe outcome in adult patients with COVID-19 presenting to the emergency department.
    Kaal A; Snel L; Dane M; van Burgel N; Ottens T; Broekman W; El Bouazzaoui L; Kolfschoten N; Schippers E; Steyerberg E; Meziyerh S; van Nieuwkoop C
    Emerg Med J; 2021 Sep; 38(9):685-691. PubMed ID: 34289966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics Predicting Mortality Risk in Hospitalized Geriatric Patients with COVID-19 Pneumonia: a Retrospective Study.
    Gulec-Balbay E; Altundal MMB; Kaypak MK; Cangur S; Kaya S
    Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.
    Velavan TP; Kuk S; Linh LTK; Lamsfus Calle C; Lalremruata A; Pallerla SR; Kreidenweiss A; Held J; Esen M; Gabor J; Neurohr EM; Shamsrizi P; Fathi A; Biecker E; Berg CP; Ramharter M; Addo MM; Kreuels B; Kremsner PG
    Sci Rep; 2021 Jul; 11(1):14471. PubMed ID: 34262116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?
    Tahir Huyut M; Huyut Z; İlkbahar F; Mertoğlu C
    Int Immunopharmacol; 2022 Apr; 105():108542. PubMed ID: 35063753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.